Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. These changes will have an impact on optimal clinical management.
⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source:
Read Full Paper at OpenAlex